Navigation Links
European Union Approves Maize with Herculex® I/Herculex® RW and Herculex® RW/ Herculex® I/Roundup Ready® Corn 2 Trait Stacks for Import, Food, Feed & Processing
Date:7/30/2010

3,prop15';s.prop5='External Link';s.eVar3=s.prop5;s.prop15='99636104';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www2.dupont.com/Our_Company/en_US/executives/schickler.html">Paul E. Schickler. "We are encouraged by these approvals and urge the Commission and EU Member States to similarly approve biotech crops for cultivation so Europe's farmers have access to the same technologies as other farmers around the world."

Herculex® RW contains the Bt trait (59122) to provide an environmentally improved means of protecting maize plants against attacks by the corn rootworm and reducing the need to use insecticides. Herculex® I contains the Bt trait (1507) to provide protection against a broad spectrum of insect pests, including corn borer, black cutworm and fall armyworm. The Roundup Ready® Corn 2 (NK603) gene for tolerance to glyphosate herbicide allows growers to effectively and efficiently control weeds in their fields, allowing the corn plants to achieve higher yields.

"These approvals tell us that the EU recognizes the extensive health and safety data supporting the use of these biotech products," said Dow AgroSciences' President and CEO Antonio Galindez.  "These authorizations are essential to ensuring that maize products can be freely traded and that the European livestock industry has continued access to the feed derived from them."

Maize products containing these traits (1507x59122 or 59122x1507xNK603) were assessed to be safe for use in food and feed by the EU's own independent scientific authority, the European Food Safety Authority (EFSA), in '/>"/>

SOURCE DuPont
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. European cooperation ensures global leadership in microelectronics
2. Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union
3. Corgenix Receives Additional European Patent, Announces Publication of Important Clinical Study on AtherOx(R) Technology
4. ChemoCentryx Reports Positive Phase I Study Results for CCX354 at the Annual European Congress of Rheumatology (EULAR)
5. PRA International Exhibits at European Hematology Association Congress
6. Vermillion Announces Issuance of European Patent
7. Glycosan BioSystems Seeks CE Mark in the European Union for HyStem-Rx, a Unique, Implantable Scaffold for Tissue Engineering
8. Aeterna Zentaris Receives Positive Opinion for Orphan Medicinal Product Designation for AEZS-108 for the Treatment of Ovarian Cancer from the Committee for Orphan Medicinal Products of the European Medicines Agency
9. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
10. The European HEALTHGRAIN consortium developed a definition for whole grain
11. A number of European companies working together to create innovative facades with nanomaterials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... North Shore Towers, a luxury co-op community based ... one of the nation’s leading combined heating and power (CHP) ... 43-year-old CHP system. The original CHP system had been maintained ... the life of the plant, GI Energy was contracted to ... recovery equipment, while maintaining continuous operation of the entire complex. ...
(Date:7/31/2014)... -- Research and Markets has announced the ... report to their offering. ... the genetic material or genomes of an organism. It ... discovery and development of diagnostic and therapeutic solutions for ... is supported by three major product segments: Instruments, Consumables, ...
(Date:7/31/2014)... July 31, 2014 Senomyx , ... company using proprietary taste science technologies to discover, ... food, beverage, and ingredient supply industries, today reported ... Company ended the second quarter with $33.6 million ... "During the past quarter Senomyx achieved another ...
(Date:7/31/2014)... SHENZHEN, China , July 31, 2014 ... an Irys™System by BGI , the ... enable comprehensive exploration of human structural variation (SV) and ... interest, including those where no reference exists. In addition, ... methods for multiplexing on the Irys System, enabling significantly ...
Breaking Biology Technology:North Shore Towers Partners with GI Energy to Install Turnkey Natural Gas-Fired Combined Heat and Power Plant 2Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 14SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 15SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 16BioNano Genomics Announces the Purchase of the Irys System by BGI 2BioNano Genomics Announces the Purchase of the Irys System by BGI 3BioNano Genomics Announces the Purchase of the Irys System by BGI 4
... 2011 Sigma Life Science, the innovative biological ...  SIAL), and King,s College London, today announced an ... for the identification and validation of microRNA (miRNA) ... detailed information, visit www.wherebiobegins.com/targetid . ...
... Reportlinker.com announces that a new market research report is available ... http://www.reportlinker.com/p0489604/Genetics-Reports-Bundle.html Report Description ... TriMark Publications reports at a15% discount off the individual reports being ... DNA Sequencing and PCR Markets. - Gene Expression ...
... Highlights First Quarter 2011: First ... to Alexandria Real Estate Equities, Inc.,s Common Stockholders of $1.15, ... Up 6% Compared to First Quarter 2010 FFO Per Share ... (Diluted) Attributable to Alexandria Real Estate Equities, Inc.,s Common Stockholders ...
Cached Biology Technology:Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 2Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 3Sigma® Life Science and King's College London Co-Developing miRNA Target Identification Technology 4Reportlinker Adds Genetics Reports Bundle 2Reportlinker Adds Genetics Reports Bundle 3Reportlinker Adds Genetics Reports Bundle 4Reportlinker Adds Genetics Reports Bundle 5Reportlinker Adds Genetics Reports Bundle 6Reportlinker Adds Genetics Reports Bundle 7Reportlinker Adds Genetics Reports Bundle 8Reportlinker Adds Genetics Reports Bundle 9Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 2Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 3Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 4Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 5Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 6Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 7Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 8Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 9Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 10Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 11Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 12Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 13Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 14Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 15Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 16
(Date:8/1/2014)... the UC Davis Center for Neuroscience and Department ... and Engineering Faculty Fellowship from the U.S. Department ... support new work on learning and memory in ... The new project aims to connect neural oscillations, ... the cortex and hippocampus, brain regions that are ...
(Date:8/1/2014)... marine mammals have officially named a species new ... sahulensis , according to the Wildlife Conservation Society ... the newly named species is the culmination of ... historical records, physical descriptions, and genetic data of ... from the coast of West Africa to the ...
(Date:8/1/2014)... in stem cell research will provide enormous opportunities ... stem cells could replicate any other cells in ... disease, repairing damaged spinal cords, treating kidney, liver ... The potential for profit is staggering. Prof. Jinhui ... this field of research still faces myriad biological, ...
Breaking Biology News(10 mins):Scientists name new species of cetacean: The Australian humpback dolphin 2Scientists name new species of cetacean: The Australian humpback dolphin 3
... steady rise in autoimmune diseases such as multiple sclerosis ... factors could be the cause of this increase. One ... excessively germ-free environment may contribute to an increase in ... play a role in increasing autoimmune disease incidence. The ...
... a chronic relapsing inflammatory disorder of the intestinal ... in the developed world. Common symptoms include abdominal ... associated with debilitating clinical complications. Researchers from the ... important clue to the susceptibility of individuals to ...
... shown that termites can tell what sort of material their ... The findings may lead to improvements in the control of ... wooden blocks and specially designed blocks made of wood and ... the blocks containing the most wood ?even though they could ...
Cached Biology News:Parasite infection may benefit MS patients 2
Human FGF R2 (alpha isoforms) MAb (Clone 98706)...
dithiothreitol, sulfhydryl reducing agent, C4H10O2S2; MW: 154.24, 97% pure (minimum), CAS No: 27565-41-9, store at -20 C ...
... the simple, phenol-free extraction of genomic DNA ... proteinase K digestion.Each kit is designed to ... of up to 25 mg of hard ... and Amplification of Genomic DNA, Nucleon DNA ...
Human LT beta R/TNFRSF3 Phycoerythrin MAb (Clone 71319)...
Biology Products: